Ulker Biskuvinayi AS (IST:ULKER) Research & Development: ₺626 Mil (TTM As of Mar. 2026)


IST:ULKER Ulker Biskuvi Sanayi AS IST:ULKER
87 GF Score
Price ₺102.40
GF Value ₺126.05
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Ulker Biskuvinayi AS Research & Development?

Ulker Biskuvinayi AS IST:ULKER +0.20% 87 Research & Development is ₺626 Mil as of Mar. 2026. GuruFocus rates IST:ULKER with a GF Score™ of 87/100 and a GF Value™ of ₺126.05 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ulker Biskuvinayi AS's Research & Development for the three months ended in Mar. 2026 was ₺167 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₺626 Mil.

Ulker Biskuvinayi AS  (IST:ULKER) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ulker Biskuvinayi AS Research & Development Related Terms

Ulker Biskuvinayi AS Research & Development Historical Data

* Premium members only.

The historical data trend for Ulker Biskuvinayi AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ulker Biskuvinayi AS Research & Development Chart

Ulker Biskuvinayi AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.79 164.65 344.64 543.37 628.46

Ulker Biskuvinayi AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 183.61 133.68 149.27 175.60 167.29
IST:ULKER
87GF Score
Ulker Biskuvi Sanayi AS IST:ULKER
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ulker Biskuvinayi AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺626 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₺626 Mil mean?
Ulker Biskuvinayi AS (IST:ULKER) has a Research & Development of ₺626 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Ulker Biskuvinayi AS and its competitors.
Is Ulker Biskuvinayi AS's Research & Development too high?
Ulker Biskuvinayi AS's current Research & Development is ₺626 Mil. Overall, Ulker Biskuvinayi AS has a GF Score™ of 87/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ulker Biskuvinayi AS's Research & Development compare to MDLZ and HSY?
Ulker Biskuvinayi AS's Research & Development of ₺626 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Consumer Packaged Goods company?
A good Research & Development depends on the Consumer Packaged Goods industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ulker Biskuvinayi AS and its competitors. Ulker Biskuvinayi AS's current Research & Development is ₺626 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ulker Biskuvinayi AS stock overvalued right now?
Based on GuruFocus' analysis, Ulker Biskuvinayi AS (IST:ULKER) is currently considered Modestly Undervalued. The stock's GF Value™ is ₺126.05, compared to a current price of ₺102.40 — trading 18.8% below its estimated fair value. The current Research & Development is ₺626 Mil. Ulker Biskuvinayi AS's overall GF Score™ is 87/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ulker Biskuvinayi AS (IST:ULKER), the current Research & Development is ₺626 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ulker Biskuvinayi AS (IST:ULKER) Overvalued in 2026?

Based on GuruFocus' analysis, Ulker Biskuvinayi AS stock appears to be undervalued. The current stock price of ₺102.40 is trading 18.8% below its estimated GF Value™ of ₺126.05. GuruFocus considers Ulker Biskuvinayi AS to be Modestly Undervalued.

Key valuation signals for IST:ULKER:

  • Research & Development: ₺626 Mil
  • GF Value™: ₺126.05 vs. price of ₺102.40 (18.8% below fair value)
  • GF Score™: 87/100 with 7 warning signs

No single metric tells the full story. See the IST:ULKER stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ulker Biskuvinayi AS Business Description

Other Exchanges UELKY:USA
Address Kysykly Mah. Ferah Cad. No:1, Buyuk Camlyca, Uskudar, Istanbul, TUR, 34692
Ulker Biskuvi Sanayi AS is engaged in manufacturing marketing, and sale of biscuits, chocolate-coated biscuits, wafers, cakes, and chocolate. The brands of the company include Ulker, Alpella, Albeni, Dido, Laviva, Cocostar, Godiva, Piko, Buklet, and others. Substantially all of the remaining revenue is from cake sales. The company earns majority of its revenue from domestic market.
87GF Score

Get the complete analysis for IST:ULKER

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺102.40
Price
₺126.05
GF Value